Roche/Genentech -- Physician Payments Report
This page provides a comprehensive analysis of Roche/Genentech's payments to physicians, as reported in the CMS Open Payments (Sunshine Act) database. DoctorPharmaData enhances this data with AI-powered analysis to help patients understand pharmaceutical company spending patterns.
Spending Summary
Roche/Genentech has made $12,085,252.35 in total payments to 0 physicians across 898 recorded transactions.
- Total Physician Spending: $12,085,252.35
- Total Physicians Paid: 0
- Total Payment Transactions: 898
Recent Payment Records
The following table shows the most recent payments from Roche/Genentech to physicians as recorded in the CMS Open Payments database.
| Doctor | Specialty | Amount | Type | Date |
|---|---|---|---|---|
| Timothy Rogers | Ophthalmology | $118.50 | meals | 2026-04-08 |
| Catherine Morris | Hematology | $10,357.04 | consulting | 2026-04-05 |
| Heather Mitchell | Neurology | $2,957.62 | consulting | 2026-04-04 |
| Nicole Lopez | Pulmonology | $9,414.35 | speaking | 2026-04-04 |
| Scott Collins | Neurology | $104.77 | meals | 2026-04-04 |
| Charles Baker | Ophthalmology | $31.74 | meals | 2026-04-01 |
| Daniel White | Neurology | $34,803.45 | consulting | 2026-03-29 |
| Elizabeth Roberts | Oncology | $18.35 | meals | 2026-03-28 |
| Timothy Rogers | Neurology | $37,908.52 | consulting | 2026-03-28 |
| Scott Collins | Oncology | $3,754.08 | general | 2026-03-28 |
| Ashley Nelson | Oncology | $1,156.47 | general | 2026-03-28 |
| Michelle Scott | Ophthalmology | $91.25 | meals | 2026-03-27 |
| Christopher Clark | Pulmonology | $26,123.62 | consulting | 2026-03-27 |
| Gregory Evans | Ophthalmology | $49.63 | meals | 2026-03-27 |
| Elizabeth Roberts | Hematology | $12,427.44 | consulting | 2026-03-26 |
Understanding Pharmaceutical Company Payment Reports
Under the Physician Payments Sunshine Act, pharmaceutical and medical device companies must report all payments and transfers of value to licensed physicians and teaching hospitals. Roche/Genentech is required to disclose every payment, including consulting fees, speaking engagements, meals, travel, research funding, and ownership interests.
A high spending total does not necessarily indicate improper behavior. Large pharmaceutical companies with extensive product portfolios naturally make more payments to physicians. However, examining the patterns of spending -- which specialties are targeted, which doctors receive the most, and what types of payments predominate -- can provide valuable insights for patients.
Related Resources
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice.